Comparative safety signals of carboplatin and cisplatin in lung cancer: a pharmacovigilance study based on FAERS

Audiologists monitoring patients on platinum-based chemotherapy should note that cisplatin carries a stronger ototoxicity signal than carboplatin per this database study, reinforcing existing monitoring guidelines — no immediate practice change beyond current ASHA/AAA...